Lucky you! Here's a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:
- Global tensions are on the rise — that could be a good thing for Elbit Systems (ESLT)
- Why Electromed (ELMD) could be an undervalued gem
-
Flex (FLEX) earns Stock of the Week status — here’s why
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Attention Investors: The 10 Best stocks for 2026-yours FREE
Today, we are inviting you to take a free peek at MarketBeat's proprietary, exclusive and up-to-the-minute list of the 10 Best Stocks to Buy in 2026. Many of these companies might appear to be nothing special at first glance. Others might be names you have heard of before and decided to pass on, but financials don't lie. Now is the time to take a look. It's yours absolutely FREE.
Get Your Copy of "10 Best Stocks to Own in 2026" Here.
Electromed makes medical devices for treating lung conditions. ELMD shares have shot up by 28.63% in the past month — however, the stock remains undervalued. The company has delivered 7 earnings beats in a row — and it has a balance sheet that is more than healthy enough to finance new growth.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $23.95 — get current quote >
Max 1-year forecast: $36.00
Why we’re watching:
- Electromed is currently tracked by 2 Wall Street analysts — both of whom issue Strong Buy ratings. See the ratings
- The average 12-month price forecast for ELMD shares currently stands at $35, and implies a 48.23% upside.
- Roth Capital researcher Kyle Bauser (a top 24% rated analyst) maintained a Strong Buy rating on the stock after the company reported its Q4 and FY 2025 earnings, and increased his price target from $29 to $35.
- Bauser referred to the quarter's results as "better-than-expected."
- Management outlined an expectation that FY 2026 will deliver double-digit revenue growth and expanded operating leverage.
- From an investment perspective, Bauser said the stock is highly undervalued in view of (1) the company's market-leading position in the underserved bronchiectasis space, and (2) the company's strong earnings profile, clean balance sheet, and improving operating efficiencies.
- Electromed shares currently rank in the top 4% of the equities that we track, giving them a Zen Rating of A.
- ELMD is currently trading at a price-to-earnings (P/E) ratio of 26.91x, which is below both industry and wider market averages. In terms of its Value Component Grade rating, the stock ranks in the 82nd percentile.
- With regard to its Sentiment Component Grade rating, Electromed ranks in the 87th percentile of equities.
- On top of that, ELMD ranks quite highly in Safety and Financials — in the top 4% and top 2% of stocks, to be exact. (See all 7 Zen Component Grades here >)
![]()
Elbit Systems develops advanced electronics and weapons systems used by militaries around the world. With global tensions on the rise and demand for high-tech defense solutions growing, Elbit’s diversified portfolio and international footprint position it as a key player in the modern defense industry.
Zen Rating: B (Buy) — see full analysis >
Recent Price: $472.00 — get current quote >
Max 1-year forecast: $540.00
Why we’re watching:
- ESLT is a bit of an under-the-radar pick — the stock currently has just 1 analyst rating, which is a Strong Buy. See the rating
- Bank of America equity researcher Ronald Epstein (a top 9% rated analyst) maintained a Strong Buy rating on Elbit Systems after the company's Q2 2025 earnings. The BofA analyst also increased his price forecast from $500 to $540.
- Epstein said they raised their 2025 EPS estimate and multiple to account for the company's stronger-than-expected growth in the quarter and the multiple expansion for defense names, saying Elbit Systems continues to deliver on soaring demand.
- Elbit Systems shares rank in the 88th percentile of the equities that our system tracks, giving them a Zen Rating of B.
- ESLT also happens to rank in the 88th percentile when it comes to Growth and Safety.
- However, Momentum is the star of the show here — Elbit Systems stock has rallied by 83.02% since the start of the year. In terms of this category, the stock ranks in the top 3% of equities. (See all 7 Zen Component Grades here >)
![]()
Flex helps design, build, and deliver products and entire supply chains across a wide variety of industries, including automotive, healthcare, and even cloud computing. It also happens to be our Stock of the Week. Right now, this is one of the highest-rated stocks in the tech sector — as well as one of the best-rounded stocks we track overall.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $53.95 — get current quote >
Max 1-year forecast: $60.00
Why we’re watching:
- FLEX is our Stock of the Week. Our Editor-in-Chief, Steve Reitmeister, explained why the stock deserves inclusion in his exclusive, 20-stock strong Zen Investor portfolio in a Monday article.
- Flex operates in more than 30 countries — which allows it to not only take advantage of the best labor markets, but also to play the tariff situation to its advantage.
- Even if we disregard the aforementioned advantage, the company is incredibly well-run — having posted 20 (yes, twenty) consecutive earnings beats.
- Flex is the 6th highest-rated stock in the Electronic Component industry, which has an Industry Rating of A.
- FLEX ranks in the top 5% of the stocks that we track — giving it a Zen Rating of A, equivalent to a Strong Buy rating.
- Speaking of Strong Buy ratings, FLEX is a favorite of Wall Street analysts — the stock is currently tracked by 7 Wall Street researchers, all of whom issue Strong Buy ratings. See the ratings
- With that in mind, it won’t come as a surprise that the stock ranks in the top 13% when it comes to Sentiment.
- That isn’t FLEX’s strongest suit, however — that title belongs to Momentum, a category in which FLEX ranks in the top 11% of equities, thanks to a 38.92% year-to-date (YTD) rally. (See all 7 Zen Component Grades here >)
![]()
What to Do Next?